Product Information
GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Cipla USA Inc., priced at $0.2471 per ML under NDC 69097036108. Its NADAC has been published 459 times since May 17, 2017.
Strength
125 mg/5mL
Manufacturer
Cipla USA Inc.NDC
69097036108
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GRISEOFULVINApproval Type
Generic (ANDA)
FDA Application
ANDA065354On Market Since
3/6/2017
Pharmacological Classes
Price Statistics
The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 459 times since May 17, 2017, and over the history we have for it it has risen 28.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2471 per ML |
|---|---|
| All-time high | $0.4099 (Dec 13, 2023) |
| All-time low | $0.1508 (Jun 21, 2017) |
| 52-week high | $0.2989 |
| 52-week low | $0.2471 |
| Median price | $0.2615 |
| Average price | $0.2790 |
| Largest weekly change | +28.2% (Jul 19, 2017) |
| Weeks tracked | 459 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the grisofulvin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Cipla USA Inc., is $0.2471 per ML (NDC 69097036108), effective Jun 24, 2026.
How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has risen 28.2%. It has been tracked across 459 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?
Since May 17, 2017, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.1508 (Jun 21, 2017) to a high of $0.4099 (Dec 13, 2023), with a median of $0.2615 per ML.
Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GRISEOFULVIN 125 MG/5 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?
GRISEOFULVIN 125 MG/5 ML SUSP (NDC 69097036108) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification